The following information was received through literature ¿preventive covered stent placement at the gastroduodenal artery stump in angiogram-negative sentinel hemorrhage after pancreaticoduodenectomy¿ published in abdominal radiology in 2021.The study aimed to evaluate the clinical outcomes of preventive covered stent placement at the gastroduodenal artery stump in patients with angiogram-negative sentinel hemorrhage after pancreaticoduodenectomy.Between july 2006 and september 2018, a total of 25 patients were evaluated, including 15 patients underwent preventive covered stent placement at the gastroduodenal artery stump and 10 patients received conservative treatments.Viabahn devices were used for patient 8 to 15.Patient 9, a (b)(6) woman experienced occlusion of the covered stent 112 days after the procedure.
|
Article citation: title: preventive covered stent placement at the gastroduodenal artery stump in angiogram-negative sentinel hemorrhage after pancreaticoduodenectomy author yuan-mao lin, et al.Https://doi.Org/10.1007/s00261-021-03123-7.Abdominal radiology (2021) 46:4995¿5006.Patient weight was unavailable.Implant date was unavailable.A review of the manufacturing records for the device was unable to be conducted as no lot number was available.The device was not returned, and information was not made available, therefore, the device was not able to be evaluated.It is unknown if these adverse events were related to the viabahn devices.Information was not made available.Cause of the event cannot be established based on the available information.Further information regarding this event was requested by gore, but no further information has been reported.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
|